Eisai Co. has announced the launch of Pariet® S”(pharmaceutical requiring guidance), which is highly effective...
What are the major plans in store at HOYA Vision Care for 2025, for the Asia market? Asia remains a key market for HOYA...
The biopharma job market has been tough, with widespread downsizing and frequent layoffs across big pharma. But the wors...
Biotech partnerships of APAC differ in a variety of ways from most global collaborations, primarily due to the unique ge...
Singapore-based biopharmaceutical company Specialised Therapeutics (ST) has announced the Australian registration of SKY...
Nuclera, a UK-based biotechnology company accelerating protein expression and optimisation through its benchtop eProtein...
Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui Fudosan, has announced the est...
Australia-based IonOpticks, developer of chromatography columns for mass spectrometry research, has announced the l...
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Adalvo Limited in the Europe...
Eli Lilly and Company has announced that the Australian Therapeutic Goods Administration (TGA) has granted marketing aut...
Ireland-headquartered Medtronic plc, a global leader in healthcare technology, has announced its intent to separate its ...
Australia-based Kailo Medical, a global leader in structured reporting for medical imaging, has announced its acquisitio...
Pfizer Inc. has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc., a leading Chinese biop...
RevolKa Ltd., a venture-backed biotech company providing a cutting-edge artificial intelligence (AI)-driven protein engi...
In a groundbreaking move, Gene Solutions, a leader in prenatal and oncology genetic testing, and NEWCL Biomedical Labora...
China-based Viva Biotech recently held the AIDD platform launch event "Enchantment of Drug Discovery," unveiling the adv...
Rznomics Inc., a South Korea-based biopharmaceutical startup specialising in RNA-based therapeutics, has entered in...
US-based Sarepta Therapeutics, Inc. has announced that the Japanese Ministry of Health, Labour, and Welfare (MHLW) has a...